Go back to check previous posters stating that phase2b design even does not need FDA approval, if I remember correctly. There are so much speculation and hype there. I like what NTRP is doing and moves quickly, and soon we know it works or not. It is done and done quickly instead of letting investors wait wait wait wait for phase2a. Logically, that reflects the faith of NTRP on their drug. I have no patient to wait for another years to know what phase2a result is and when next trial starts.
Market Data 
Markets 
AI
